China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
https://youtu.be/wLck3xmO4A8
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.